Archive for September, 2008
Tuesday 30 September 2008 @ 7:09 pm
![]() NHS Choices |
Scientists identify new bone protecting protein: therapy hope for …
Arthritis Research Campaign, UK - The Arthritis Research Campaign-funded team believe their work could help develop new, possibly safer therapies for conditions such as osteoporosis and … Protein and arthritis |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Tuesday 30 September 2008 @ 6:09 pm
|
Arzoxifene Demonstrates Efficacy on Osteoporosis Prevention …
DG News - In their 2-year, phase 3, randomised study, Dr. Utian and colleagues evaluated the efficacy of arzoxifene on osteoporosis prevention through assessments of … |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Tuesday 30 September 2008 @ 6:09 pm
|
EMEA Approves Novartis´ Aclasta/Reclasta for Osteoporosis in Men
Network Médica, Argentina - The European health authorities have approved Novartis´ osteoporosis drug Aclasta – called Reclasta in the US - for use in men, as well as broadening its … |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Tuesday 30 September 2008 @ 6:09 pm
![]() RTT News |
Glaxo ends study on NPS osteoporosis drug
CNNMoney.com - Osteoporosis is a disease which reduces bone density and strength, increasing the risk for bone fractures. Ronacalaret was being developed for treatment of … NPS Pharma says Glaxo stops osteoporosis drug study NPS Pharmaceuticals Announces End of Study with Experimental … NPS says GlaxoSmithKline ends osteoporosis study with Ronacaleret … |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Tuesday 30 September 2008 @ 6:09 pm
|
Once-yearly Aclasta® approved in EU to treat osteoporosis in men …
Prdomain Business Register (press release), India - The European Commission has approved once-yearly Aclasta®* (zoledronic acid 5 mg) for the treatment of osteoporosis in men who are at increased risk of … |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Tuesday 30 September 2008 @ 5:09 pm
|
Vitamin D Added to FDA Osteoporosis Risk-Reduction Health Claim
MarketWatch - the US Food and Drug Administration (FDA) announced today that it has amended its osteoporosis risk reduction health claim to reflect the importance of … Vitamin D, calcium supplements not considered health risks |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Tuesday 30 September 2008 @ 5:09 pm
|
Operative management of a subtrochanteric fracture in severe …
7thSpace Interactive (press release), NY - Case presentationWe report a case with severe osteoporosis who sustained a subtrochanteric fracture and was managed with a Dynamic condylar screw DCS. … |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Tuesday 30 September 2008 @ 4:09 pm
|
GSK Stops Phase II Study of NPS Osteoporosis Drug.
Therapeutics Daily (subscription) (press release), PA - NPS Pharmaceuticals Inc. said partner GlaxoSmithKline plc prematurely halted a Phase II trial of osteoporosis drug Ronacaleret (SB-751689) after a planned … |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Tuesday 30 September 2008 @ 4:09 pm
|
Bazedoxifene Causes No Increase in Breast Density: Presented at NAMS
DG News - [Presentation tile: The Effects of Bazedoxifene on Mammographic Breast Density in Postmenopausal Women With Osteoporosis. Abstract S-6] Bazedoxifene Demonstrates No Significant Increase of Vasomotor … |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Tuesday 30 September 2008 @ 4:09 pm
|
EU approves Novartis' bone drug for use in men
Reuters - VX: Quote, Profile, Research, Stock Buzz) osteoporosis drug Aclasta for the use in men and broadened the drug's label, the Swiss drugmaker said on Tuesday. … |
More: continued here
If you like this post, please buy me a beer for $3 8-)




















